1 Evolutionary Genomics Inc Receivables Turnover Ratio (FNAM), from the fourth quarter 2022 to the fourth quarter 2021 current and historic results, rankings and more - CSIMarket

Company Name, Ticker, Industry, else..

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Evolutionary Genomics Inc (FNAM)

Sector • Healthcare Industry • Medical Laboratories

Industry • Medical Laboratories

Sector • Healthcare

Evolutionary Genomics Inc Accounts Receivables Turnover Ratio from the fourth quarter 2022 to the fourth quarter 2021

Quarterly Results, Trends, Rankings, Statistics

According to Evolutionary Genomics Inc Balance Sheet, in the fourth quarter 2022, company has not reported any Accounts receivable.
See Evolutionary Genomics Inc Balance Sheet

If we take a look into Healthcare sector Evolutionary Genomics Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Evolutionary Genomics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

FNAM Receivables Turnover Ratio	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-	-	-	-	-
Receivable Turnover Ratio (TTM)	-	-	-	-	-
FNAM's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	-	-	-	-	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

FNAM Company Profile • Back to FNAM Efficiency Comparisons • Compare FNAM Receivables Turnover Ratio to its Competitors

Financial Statements
Evolutionary Genomics Inc 's Accounts Receivable	$ 0 Millions	Visit FNAM's Balance sheet
Evolutionary Genomics Inc 's Sales TTM	$ 0 Millions	Visit FNAM's Income Statement
Sources of FNAM's Revenues		Visit FNAM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
FNAM's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
FNAM's Growth Rates	FNAM's Roa	FNAM's Inventory Turnover Ratio	FNAM's Dividend Comparisons
FNAM's Profitability Ratios	FNAM's Roi	FNAM's Asset Turnover Ratio	FNAM's Dividend Growth
FNAM's Valuation Ratios	FNAM's Roe	FNAM's Financial Strength Ratios	FNAM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Dec 31 2022

Receivable at quarter ending Dec 31 2022

Date modified: 2026-08-29T07:14:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.